dr. martens plc - DRMTY

DRMTY

Close Chg Chg %
2.03 -0.20 -9.85%

Closed Market

1.83

-0.20 (9.85%)

Volume: 500.00

Last Updated:

Jun 3, 2026, 9:30 AM EDT

Company Overview: dr. martens plc - DRMTY

DRMTY Key Data

Open

$1.83

Day Range

1.83 - 1.83

52 Week Range

1.43 - 2.60

Market Cap

$937.95M

Shares Outstanding

478.54M

Public Float

N/A

Beta

0.98

Rev. Per Employee

N/A

P/E Ratio

29.68

EPS

N/A

Yield

292.97%

Dividend

$0.02

EX-DIVIDEND DATE

Mar 6, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.05K

 

DRMTY Performance

1 Week
 
0.00%
 
1 Month
 
10.91%
 
3 Months
 
3.39%
 
1 Year
 
28.42%
 
5 Years
 
N/A
 

DRMTY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Dr. Martens Plc - DRMTY

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
1.20B 1.10B 1.00B 1.03B
Sales Growth
-2.94% -8.51% -8.80% +2.02%
Cost of Goods Sold (COGS) incl D&A
525.32M 470.00M 444.70M 439.01M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
65.24M 90.81M 92.74M 92.06M
Depreciation
55.13M 83.53M 84.96M 83.62M
Amortization of Intangibles
10.11M 7.28M 7.78M 8.44M
COGS Growth
+5.02% -10.53% -5.38% -1.28%
Gross Income
678.80M 631.65M 560.02M 586.02M
Gross Income Growth
-8.33% -6.95% -11.34% +4.64%
Gross Profit Margin
+56.37% +57.34% +55.74% +57.17%
2023 2024 2025 2026 5-year trend
SG&A Expense
449.12M 472.89M 482.71M 482.83M
Research & Development
- - - -
-
Other SG&A
449.12M 472.89M 482.71M 482.83M
SGA Growth
+6.27% +5.29% +2.08% +0.02%
Other Operating Expense
- - - -
-
Unusual Expense
- 4.69M 26.28M 27.47M
EBIT after Unusual Expense
224.98M 158.76M 51.03M 75.71M
Non Operating Income/Expense
(10.59M) (1.51M) 765.40K 5.23M
Non-Operating Interest Income
2.29M 3.77M 4.85M 4.96M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
22.51M 40.44M 40.57M 37.12M
Interest Expense Growth
+9.87% +79.67% +0.30% -8.49%
Gross Interest Expense
22.51M 40.44M 40.57M 37.12M
Interest Capitalized
- - - -
-
Pretax Income
191.88M 116.81M 11.23M 43.82M
Pretax Income Growth
-34.45% -39.12% -90.39% +290.35%
Pretax Margin
+15.94% +10.60% +1.12% +4.28%
Income Tax
36.71M 29.89M 5.49M 11.93M
Income Tax - Current - Domestic
31.78M 20.85M 2.04M 9.92M
Income Tax - Current - Foreign
5.18M 8.04M 4.85M 4.29M
Income Tax - Deferred - Domestic
(240.75K) 1.00M (1.40M) (2.28M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
155.16M 86.92M 5.74M 31.89M
Minority Interest Expense
- - - -
-
Net Income
155.16M 86.92M 5.74M 31.89M
Net Income Growth
-37.31% -43.98% -93.40% +455.59%
Net Margin Growth
+12.89% +7.89% +0.57% +3.11%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
155.16M 86.92M 5.74M 31.89M
Preferred Dividends
- - - -
-
Net Income Available to Common
155.16M 86.92M 5.74M 31.89M
EPS (Basic)
0.3102 0.1767 0.0119 0.0661
EPS (Basic) Growth
-37.32% -43.04% -93.27% +455.46%
Basic Shares Outstanding
500.25M 491.75M 481.15M 482.35M
EPS (Diluted)
0.31 0.1764 0.0118 0.0651
EPS (Diluted) Growth
-37.20% -43.10% -93.31% +451.69%
Diluted Shares Outstanding
500.60M 492.80M 487.05M 489.80M
EBITDA
294.92M 249.57M 170.05M 195.25M
EBITDA Growth
-19.85% -15.38% -31.86% +14.82%
EBITDA Margin
+24.49% +22.65% +16.92% +19.05%

Dr. Martens Plc in the News